Skip to content

Digital Twin

Digital Twin - Digital Twin

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51358
Enrollment
38
Registered
2022-03-03
Start date
2022-03-28
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glucosemetabolismestoornissen postprandial lipid and glucose metabolism

Interventions

None listed

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Male or female - Age 45-75 y - BMI 25-35 kg/m2 - Suitable veins for insertion of cannula

Exclusion criteria

Exclusion criteria: - Having a gastro-intestinal disease, such as celiac disease, Crohn*s disease, or Ulcerative colitis - Having a history of intestinal surgery that might interfere with study outcomes, as determined by the medical supervisor. This does not include an appendectomy or cholecystectomy - Presence of significant systemic diseases, such as diabetes mellitus, cancer, cardiovascular disease or respiratory disease, as determined by the medical supervisor - Use of medications known to interfere with glucose or lipid homeostasis (e.g. corticosteroids, cholesterol-lowering medication, insulin, metformin), as determined by medical supervisor - Blood clotting disorders - Unstable body weight (weight gain or loss >3 kg in the past three months) - Reported slimming, medically prescribed or other extreme diets - Alcohol consumption >21 glasses a week - Anaemia (Hb values

Design outcomes

Primary

MeasureTime frame
The primary study parameter is the postprandial triglyceride responses in blood upon a mixed meal challenge.

Secondary

MeasureTime frame
The secondary study parameters are: postprandial glucose and insulin responses in the blood upon a mixed meal challenge, and extensive phenotyping of the subjects by collecting data on fasting blood profiles of micronutrients, metabolites, and proteins, continuous blood glucose levels (Freestyle Libre), body fat composition (DEXA), liver fat percentage (MRI), habitual dietary intake (FFQ), and physical activity (ActivPAL3).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)